1089P Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 7-y results from CheckMate 238P.A. Ascierto,M. Del Vecchio, B. Merelli,H. Gogas,A.M. Arance Fernandez,S. Dalle,C.L. Cowey,M. Schenker,J.J. Grob,V. Chiarion Sileni,I. Marquez-Rodas,M.O. Butler,A.M. Di Giacomo, M. Pe Benito, R. Soomro, M. Askelson, J.S. Weber,J. LarkinAnnals of Oncology（2023）引用 0|浏览19暂无评分关键词nivolumab melanoma,ipilimumabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
